Back
Day Range
$70.67
$71.85
52-Week Range
$57.65
$89.77
Volume
5,974,726
50D / 200D Avg
$79.49
/
$76.90
Prev Close
$71.65
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 15.5 | 0.3 |
| P/B | 3.1 | 2.9 |
| ROE % | 22.1 | 3.7 |
| Net Margin % | 10.1 | 3.8 |
| Rev Growth 5Y % | 4.1 | 10.0 |
| D/E | 1.0 | 0.2 |
Analyst Price Target
Hold
$91.70
+29.2%
Low: $77.00
High: $105.00
Forward P/E
14.1
Forward EPS
$5.07
EPS Growth (est.)
+0.0%
Est. Revenue
22 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2029 |
$7.11
$6.93 – $7.24
|
25 B | 2 |
| FY2028 |
$6.23
$5.80 – $6.97
|
24 B | 7 |
| FY2027 |
$5.60
$5.28 – $5.74
|
23 B | 14 |
Key Takeaways
Revenue grew 4.07% annually over 5 years — modest growth
ROE of 22.14% indicates high profitability
Generating 1.51B in free cash flow
Capital efficient — spends only 2.34% of revenue on capex
Growth
Revenue Growth (5Y)
4.07%
Revenue (1Y)4.84%
Earnings (1Y)4.57%
FCF Growth (3Y)-6.26%
Quality
Return on Equity
22.14%
ROIC10.16%
Net Margin10.10%
Op. Margin13.39%
Safety
Debt / Equity
0.96
Current Ratio1.18
Interest Coverage6.14
Valuation
P/E Ratio
15.52
P/B Ratio3.12
EV/EBITDA13.70
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.84% | Revenue Growth (3Y) | 2.71% |
| Earnings Growth (1Y) | 4.57% | Earnings Growth (3Y) | 15.29% |
| Revenue Growth (5Y) | 4.07% | Earnings Growth (5Y) | -1.87% |
| Profitability | |||
| Revenue (TTM) | 20.63B | Net Income (TTM) | 2.08B |
| ROE | 22.14% | ROA | 5.65% |
| Gross Margin | 39.99% | Operating Margin | 13.39% |
| Net Margin | 10.10% | Free Cash Flow (TTM) | 1.51B |
| ROIC | 10.16% | FCF Growth (3Y) | -6.26% |
| Safety | |||
| Debt / Equity | 0.96 | Current Ratio | 1.18 |
| Interest Coverage | 6.14 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 15.52 | P/B Ratio | 3.12 |
| P/S Ratio | 1.57 | PEG Ratio | 4.13 |
| EV/EBITDA | 13.70 | Dividend Yield | 0.00% |
| Market Cap | 32.34B | Enterprise Value | 37.83B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.63B | 19.67B | 19.55B | 18.34B | 17.59B |
| Net Income | 2.08B | 1.99B | 1.57B | 1.92B | 2.25B |
| EPS (Diluted) | 4.55 | 4.34 | 3.02 | 4.22 | 4.90 |
| Gross Profit | 8.25B | 8.21B | 7.92B | 7.18B | 7.17B |
| Operating Income | 2.76B | 2.63B | 2.44B | 2.52B | 2.80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 36.91B | 33.09B | 32.45B | 27.54B | 26.31B |
| Total Liabilities | 26.31B | 24.44B | 25.14B | 17.95B | 9.41B |
| Shareholders' Equity | 10.38B | 8.45B | 7.13B | 9.36B | 16.66B |
| Total Debt | 10.00B | 9.38B | 9.86B | 8.64B | 437.00M |
| Cash & Equivalents | 4.51B | 2.89B | 2.50B | 1.45B | 556.00M |
| Current Assets | 10.70B | 9.52B | 9.01B | 7.82B | 6.54B |
| Current Liabilities | 9.11B | 9.55B | 8.98B | 7.19B | 6.76B |